<p>Component stock Q32 Bio rose by 33.65%, Summit Therapeutics Plc. increased by 16.32%, and Iovance Biotherapeutics rose by 15.21%, ranking third. IGM Biosciences fell by 5.19%, ranking third from the bottom, Grail dropped by 5.37%, and Prime Medicine decreased by 5.83%</p>

PRME

SMMT

IGMS

QTTB

<p>The Nasdaq Biotechnology Index rose 1.85%, outperforming the three major U.S. stock indices. Among the constituent stocks, Q32 Bio had the largest increase, closing up 33.65%; Summit Therapeutics Plc. rose 16.32%; Iovance Biotherapeutics increased by 15.21%. IGM Biosciences fell 5.19%, Grail dropped 5.37%, and Prime Medicine decreased by 5.83%</p>

Wallstreetcn

Prime Medicine

Summit Therapeutics

IGM Biosciences

Q32 Bio

The Nasdaq Biotechnology Index closed up 1.85%, outperforming both small-cap indices and the three major U.S. stock indices

納斯達克生物科技指數收漲 1.85%，和小盤股指都表現好於美國三大股指